FDA 483 - Southern Sales & Services Inc. - August 07, 2025

An FDA inspection of Southern Sales & Services Inc., an OTC drug manufacturer and repacker in Fort Lauderdale, FL, revealed significant deficiencies in their quality system. The firm failed to follow its written stability testing program, did not conduct complete annual product reviews, and lacked an adequate continuous CGMP training program for employees, including production personnel. These issues indicate a lack of robust quality control and compliance with good manufacturing practices.